Neuraxis, Inc. (NRXS)
NYSE · Electromedical & Electrotherapeutic Apparatus · Manufacturing · CIK 1933567 · fiscal year ends in Dec
Closing price $7.16 on 30 Oct 2026; 52-week range $2.31 to $8.81.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $5.3M
- Revenue growth
- 65.2%
- Net income, last twelve months
- -$7.7M
- Earnings per share
- -$0.77
- Gross margin
- 85.6%
- Operating margin
- -144.5%
- Net margin
- -144.4%
- Return on equity
- -114.0%
- Market value
- $89.3M
- Cash
- $8.3M
- Debt
- $42.7K
- Debt to equity
- 0.01
- Shares outstanding
- 12.5M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $3.6M | -$7.8M | -$7.8M | -$0.95 | -$6.5M | 10-K filed 19 Mar 2026 |
| FY2024 | 31 Dec 2024 | $2.7M | -$7.2M | -$8.2M | -$1.22 | -$6.1M | 10-K filed 20 Mar 2025 |
| FY2023 | 31 Dec 2023 | $2.5M | -$6.7M | -$14.6M | -$4.50 | -$6.7M | 10-K filed 16 Apr 2024 |
| FY2022 | 31 Dec 2022 | $2.7M | -$3.4M | -$4.8M | -$2.77 | -$2.3M | 10-K filed 16 Apr 2024 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $1.9M | -$2.1M | -$0.19 |
| Q1 FY2026 | 31 Mar 2026 | $1.6M | -$1.8M | -$0.18 |
| Q4 FY2025 | 31 Dec 2025 | $968.1K | -$1.7M | -$0.16 |
| Q3 FY2025 | 30 Sep 2025 | $811.4K | -$2.1M | -$0.24 |
| Q2 FY2025 | 30 Jun 2025 | $894.1K | -$1.7M | -$0.22 |
| Q1 FY2025 | 31 Mar 2025 | $895.7K | -$2.3M | -$0.33 |
| Q4 FY2024 | 31 Dec 2024 | $761.2K | -$1.4M | -$0.23 |
| Q3 FY2024 | 30 Sep 2024 | $666.6K | -$1.8M | -$0.25 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| All other States | $1.2M | 34.9% |
| CA | $898.2K | 25.2% |
| OH | $578.8K | 16.2% |
| MA | $265.2K | 7.4% |
| IL | $222.4K | 6.2% |
| WI | $215.4K | 6.0% |
| FL | $143.9K | 4.0% |
Company events
The newest 8-K filings of 36 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 14 Oct 2026 | 8-K | Other events | 8.01 |
| 19 Aug 2026 | 8-K | Leadership change, Other events | 5.02, 8.01 |
| 10 Jul 2026 | 8-K | Other events | 8.01 |
| 12 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 22 Apr 2026 | 8-K | Other events | 8.01, 9.01 |
| 21 Apr 2026 | 8-K | Results | 2.02 |
| 24 Oct 2025 | 8-K | Other events | 8.01, 9.01 |
| 23 Oct 2025 | 8-K | Results | 2.02 |
| 2 Sep 2025 | 8-K | Material agreement | 1.01, 9.01 |
| 3 Jul 2025 | 8-K | Leadership change, Material agreement, Agreement ended | 1.01, 1.02, 5.02, 9.01 |
| 4 Jun 2025 | 8-K | Shareholder vote | 5.07 |
| 28 May 2025 | 8-K | Investor update | 7.01, 9.01 |
Every filing
The newest filings with the SEC of 108 held.
| Filed | Form | Period |
|---|---|---|
| 14 Oct 2026 | 8-K | 14 Oct 2026 |
| 19 Aug 2026 | 8-K | 24 Jul 2026 |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 3 Aug 2026 | EFFECT | – |
| 30 Jul 2026 | S-3/A | – |
| 23 Jul 2026 | S-3 | – |
| 10 Jul 2026 | S-8 | – |
| 10 Jul 2026 | 8-K | 9 Jul 2026 |
| 12 Jun 2026 | 8-K | 10 Jun 2026 |
| 12 May 2026 | 10-Q | 31 Mar 2026 |
| 28 Apr 2026 | DEFA14A | – |
| 28 Apr 2026 | DEF 14A | 10 Jun 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 8 Oct 2026 | Carrico Brian Allen, Chief Executive Officer | Purchase | 268 | $4.84 | $1.3K | 227,604 | 8 Oct 2026 |
| 8 Oct 2026 | Carrico Thomas Joeseph, CRO, CCO, CPO | Purchase | 328 | $4.84 | $1.6K | 199,673 | 8 Oct 2026 |
| 8 Oct 2026 | Henrichs Timothy Robert, Chief Financial Officer | Purchase | 1,937 | $4.84 | $9.4K | 9,530 | 8 Oct 2026 |
| 1 Apr 2026 | Henrichs Timothy Robert, Chief Financial Officer | Purchase | 7,593 | $1.96 | $14.9K | 7,593 | 3 Apr 2026 |
| 1 Apr 2026 | Carrico Thomas Joeseph, CRO, CCO, CPO | Purchase | 667 | $1.96 | $1.3K | 331,903 | 3 Apr 2026 |
| 1 Apr 2026 | Carrico Brian Allen, Chief Executive Officer | Purchase | 8,060 | $1.96 | $15.8K | 348,178 | 3 Apr 2026 |
| 12 Feb 2026 | Hannasch Brian, 10% owner | Purchase | 40,000 | $4.92 | $196.8K | 1,211,522 | 13 Feb 2026 |
| 11 Feb 2026 | Hannasch Brian, 10% owner | Purchase | 40,000 | $4.65 | $186.0K | 1,171,522 | 13 Feb 2026 |
| 23 Dec 2025 | Aharon Gil, Director | Purchase | 286,138 | $3.52 | $1.0M | 286,138 | 29 Dec 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 3 Aug 2026 | BIGGER CAPITAL FUND L P | 13G amended | 6.67% | 831.7K |
| 1 May 2026 | BIGGER CAPITAL FUND L P | 13G amended | 6.64% | 764.2K |
| 3 Feb 2026 | BIGGER CAPITAL FUND L P | 13G amended | 9.17% | 977.0K |
| 12 Nov 2025 | BIGGER CAPITAL FUND L P | 13G amended | 8.6% | 915.7K |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 412.8K | +10.74% | 2.33 |
| 30 Sep 2026 | 372.8K | -1.13% | 1.58 |
| 15 Sep 2026 | 377.1K | +51.66% | 5.38 |
| 31 Aug 2026 | 248.6K | -39.47% | 3.66 |
| 14 Aug 2026 | 410.8K | -1.77% | 3.62 |
| 31 Jul 2026 | 418.1K | -11.26% | 5 |
| 15 Jul 2026 | 471.2K | +31.37% | 7.8 |
| 30 Jun 2026 | 358.7K | -29.33% | 3.57 |
Funds that hold it
From each fund's latest Form 13F.
35 funds held it at 30 Jun 2026: 24 added and 4 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| AIGH Capital Management LLC | 519,938 | $3.8M | +119,938 |
| Rosalind Advisors, Inc. | 508,055 | $3.0M | +221,917 |
| Vanguard Capital Management LLC | 335,793 | $2.5M | +109,926 |
| Money Concepts Capital Corp. | 228,029 | $1.7M | +2,474 |
| Renaissance Technologies LLC | 169,400 | $1.2M | +92,446 |
| Marshall Wace, LLP | 128,755 | $941.2K | +50,060 |
| Parsons Capital Management Inc. | 117,808 | $861.2K | +1,082 |
| Panoramic Capital, LLC | 115,000 | $840.6K | -75,000 |
| Geode Capital Management, LLC | 96,361 | $704.7K | +3,256 |
| Citadel Advisors LLC | 85,053 | $621.7K | +85,053 |
Peers
Companies in the same industry.
- Medtronic plc (MDT): revenue $37.5B, market value $123.6B
- LivaNova plc (LIVN): revenue $1.5B, market value $4.3B
- Integer Holdings Corp. (ITGR): revenue $1.8B, market value $4.3B
- Axogen, Inc. (AXGN): revenue $266.9M, market value $2.9B
- TransMedics Group, Inc. (TMDX): revenue $668.5M, market value $2.3B
- Conmed Corp. (CNMD): revenue $1.4B, market value $1.3B
- Ceribell, Inc. (CBLL): revenue $102.0M, market value $1.0B
- CapsoVision, Inc. (CV): revenue $13.9M, market value $341.7M
- Electromed, Inc. (ELMD): revenue $73.8M, market value $225.0M
- Edap TMS SA (FOCL): revenue –, market value $157.6M